Use of intravenous cyclophosphamide in the prevention of corneal melt: justified or not?

Rheumatology (Oxford). 2005 Feb;44(2):257-8. doi: 10.1093/rheumatology/keh442. Epub 2005 Jan 5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Arthritis, Rheumatoid / complications
  • Corneal Ulcer / drug therapy*
  • Cyclophosphamide / administration & dosage*
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Infusions, Intravenous
  • Middle Aged
  • Treatment Outcome

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide